Search

Author/Creator Koornstra, Rutger

1. Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial. Issue 5 (May 2021)

Authors:
Eggermont, Alexander M M; Blank, Christian U; Mandalà, Mario; Long, Georgina V; Atkinson, Victoria G; Dalle, Stéphane; Haydon, Andrew M; Meshcheryakov, Andrey; Khattak, Adnan; Carlino, Matteo S; Sandhu, Shahneen; Larkin, James; Puig, Susana; Ascierto, Paolo A; Rutkowski, Piotr; Schadendorf, Dirk;...
Journal:
Lancet oncology
Issue:
Volume 22:Issue 5(2021)
Page Start:
643
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): health-related quality-of-life results from a double-blind, randomised, controlled, phase 3 trial. Issue 5 (May 2021)

Authors:
Bottomley, Andrew; Coens, Corneel; Mierzynska, Justyna; Blank, Christian U; Mandalà, Mario; Long, Georgina V; Atkinson, Victoria G; Dalle, Stéphane; Haydon, Andrew M; Meshcheryakov, Andrey; Khattak, Adnan; Carlino, Matteo S; Sandhu, Shahneen; Puig, Susana; Ascierto, Paolo A; Larkin, James; Loriga...
Journal:
Lancet oncology
Issue:
Volume 22:Issue 5(2021)
Page Start:
655
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Preclinical exploration of combining plasmacytoid and myeloid dendritic cell vaccination with BRAF inhibition. Issue 1 (December 2016)

Authors:
Tel, Jurjen; Koornstra, Rutger; Haas, Nienke; Deutekom, Vincent; Westdorp, Harm; Boudewijns, Steve; Erp, Nielka; Blasio, Stefania; Gerritsen, Winald; Figdor, Carl; Vries, I.; Hato, Stanleyson
Journal:
Journal of translational medicine
Issue:
Volume 14:Issue 1(2016)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Prognostic and predictive value of AJCC-8 staging in the phase III EORTC1325/KEYNOTE-054 trial of pembrolizumab vs placebo in resected high-risk stage III melanoma. (July 2019)

Authors:
Eggermont, Alexander M.M.; Blank, Christian U.; Mandala, Mario; Long, Georgina V.; Atkinson, Victoria G.; Dalle, Stéphane; Haydon, Andrew; Lichinitser, Mikhail; Khattak, Adnan; Carlino, Matteo S.; Sandhu, Shahneen; Larkin, James; Puig, Susana; Ascierto, Paolo A.; Rutkowski, Piotr; Schadendorf, Di...
Journal:
European journal of cancer
Issue:
Volume 116(2019)
Page Start:
148
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Real-world healthcare costs of ipilimumab in patients with advanced cutaneous melanoma in The Netherlands. Issue 6 (July 2018)

Authors:
Franken, Margreet G.; Leeneman, Brenda; Jochems, Anouk; Schouwenburg, Maartje G.; Aarts, Maureen J.B.; van Akkooi, Alexander C.J.; van den Berkmortel, Franchette W.P.J.; van den Eertwegh, Alfonsus J.M.; de Groot, Jan Willem B.; van der Hoeven, Koos J.M.; Hospers, Geke A.P.; Kapiteijn, Ellen; Koor...
Journal:
Anti-cancer drugs
Issue:
Volume 29:Issue 6(2018)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Reply to E. Hindié. Issue 8 (10th March 2021)

Authors:
Eggermont, Alexander M. M.; Blank, Christian U.; Mandala, Mario; Long, Georgina V.; Atkinson, Victoria G.; Dalle, Stéphane; Haydon, Andrew M.; Meshcheryakov, Andrey; Khattak, Adnan; Carlino, Matteo S.; Sandhu, Shahneen; Larkin, James; Puig, Susana; Ascierto, Paolo A.; Rutkowski, Piotr; Schadendor...
Journal:
Journal of clinical oncology
Issue:
Volume 39:Issue 8(2021)
Page Start:
944
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗